Written Question·Department for Science, Innovation and Technology·UIN 32491
AstraZeneca: Merseyside
Tabled: 21 February 2025
Answered: 3 March 2025
Question
Clive Jones
Liberal Democrat — Wokingham
To ask the Secretary of State for Science, Innovation and Technology, if he will make it his policy to conduct a lessons learned review following the negotiations with AstraZeneca for investment in Speke.
Answer
Feryal ClarkAstraZeneca’s decision not to invest in Speke is deeply disappointing. The Government regularly reviews it’s grant process and routinely seeks applicant feedback. The Government also continues to engage positively with AstraZeneca, including on the new In...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 32491) →